tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LABP

AbbVie completes the acquisition of Landos Biopharma
The FlyAbbVie completes the acquisition of Landos Biopharma
7M ago
ABBV
LABP
Landos Biopharma’s Latest Deal Faces Tough Regulatory Gauntlet: HSR Act and FTC Scrutiny May Impose Delays and Costs
PremiumCompany Announcements
Landos Biopharma’s Latest Deal Faces Tough Regulatory Gauntlet: HSR Act and FTC Scrutiny May Impose Delays and Costs
8M ago
LABP
Landos Biopharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Landos Biopharma downgraded to Neutral from Buy at H.C. Wainwright
9M ago
LABP
This Biopharma Stock Outperformed MSTR and SMCI in March 2024
PremiumMarket News
This Biopharma Stock Outperformed MSTR and SMCI in March 2024
9M ago
ABBV
LABP
Landos Biopharma’s Definitive Merger with AbbVie Subsidiary
PremiumCompany Announcements
Landos Biopharma’s Definitive Merger with AbbVie Subsidiary
9M ago
8K
LABP
Landos Biopharma Inc trading resumes
PremiumThe FlyLandos Biopharma Inc trading resumes
9M ago
LABP
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
Premium
The Fly
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
9M ago
ABBV
LABP
AbbVie to acquire Landos Biopharma got $20.42 per share in cash
Premium
The Fly
AbbVie to acquire Landos Biopharma got $20.42 per share in cash
9M ago
ABBV
LABP
AbbVie to acquire Landos Biopharma for $20.42 per share in cash
PremiumThe Fly
AbbVie to acquire Landos Biopharma for $20.42 per share in cash
9M ago
ABBV
LABP
Landos Biopharma Inc trading halted, news pending
PremiumThe Fly
Landos Biopharma Inc trading halted, news pending
9M ago
LABP
Landos Biopharma reports Q4 EPS (99c) vs ($1.30) last year
PremiumThe Fly
Landos Biopharma reports Q4 EPS (99c) vs ($1.30) last year
9M ago
LABP
Landos Biopharma, Inc. (LABP) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Landos Biopharma, Inc. (LABP) Q4 Earnings Cheat Sheet
9M ago
LABP
Landos Biopharma publishes results of NX-13 Phase 1b study in UC
PremiumThe FlyLandos Biopharma publishes results of NX-13 Phase 1b study in UC
1y ago
LABP
Landos Biopharma reports Q3 EPS (94c) vs ($1.96) last year
Premium
The Fly
Landos Biopharma reports Q3 EPS (94c) vs ($1.96) last year
1y ago
LABP
Landos Biopharma announces strategic research collaboration with KU Leuven
Premium
The Fly
Landos Biopharma announces strategic research collaboration with KU Leuven
1y ago
LABP
Landos Biopharma reports Q2 EPS (63c) vs ($2.80) last year
PremiumThe Fly
Landos Biopharma reports Q2 EPS (63c) vs ($2.80) last year
1y ago
LABP
Landos Biopharma reports Q4 EPS (13c), consensus (19c)
PremiumThe Fly
Landos Biopharma reports Q4 EPS (13c), consensus (19c)
2y ago
LABP
Landos announces acceptance of NX-13 abstract in UC treatment
PremiumThe Fly
Landos announces acceptance of NX-13 abstract in UC treatment
2y ago
LABP
Landos Biopharma announces abstract on NX-13 to be presented at ECCO
PremiumThe Fly
Landos Biopharma announces abstract on NX-13 to be presented at ECCO
2y ago
LABP
Jefferies cuts Landos to Underperform with no major catalysts seen for 2 years
PremiumThe FlyJefferies cuts Landos to Underperform with no major catalysts seen for 2 years
2y ago
LABP
Landos Biopharma downgraded to Underperform from Hold at Jefferies
Premium
The Fly
Landos Biopharma downgraded to Underperform from Hold at Jefferies
2y ago
LABP
Landos Biopharma provides update on clinical development plans
Premium
The Fly
Landos Biopharma provides update on clinical development plans
2y ago
LABP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >